Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279369 · ClinicalTrials.gov registry record
The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta
A clinical trial, sponsored by Winthrop University Hospital.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01279369 is a clinical trial that was terminated before completion, run by Winthrop University Hospital. The registered enrollment target is 3 participants.
The verdict
NCT01279369 was terminated before completion, sponsored by Winthrop University Hospital.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the presence of fetal fibronectin in the cervicovaginal secretions of pregnant patients with minor maternal trauma predicts impending preterm delivery due to abruptio placenta.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01279369
The ClinicalTrials.gov registry entry for NCT01279369 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winthrop University Hospital, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01279369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01279369 about?
NCT01279369 is a clinical study titled "The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta". The purpose of this study is to determine if the presence of fetal fibronectin in the cervicovaginal secretions of pregnant patients with minor maternal trauma predicts impending preterm delivery due to abruptio placenta.
What is the current status of trial NCT01279369?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2009-10. Estimated completion is 2012-10.
Who is sponsoring clinical trial NCT01279369?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.